JENNA STURGEON: Open Payments
NPI 1023348893 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,263 in 69 payments from 26 companies in 2025. Trend: 2023 $623 · 2024 $2,372 · 2025 $1,263
Food & beverage: $1,263
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 10 | $149 |
| Madrigal Pharmaceuticals | 4 | $113 |
| Radius Health, Inc. | 5 | $99 |
| Sequel Med Tech, LLC | 2 | $83 |
| BETA BIONICS, INC. | 6 | $76 |
| Novartis Pharmaceuticals Corporation | 4 | $64 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $61 |
| Novo Nordisk Inc | 3 | $57 |
| RECORDATI_RARE_DISEASES_INC. | 3 | $53 |
| Insulet Corporation | 3 | $51 |
Products named: REZDIFFRA, GVOKE HYPOPEN, TWIIST, Tymlos, iLet Bionic Pancreas, LEQVIO, JARDIANCE, RECORLEV.
Industry payments across AZ — which companies pay providers there.
